Director
DIN: 08904050
Ram Shankar Shukla is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SENBIAN PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08904050.Ram Shankar Shukla is currently involved in 2 different roles. Their most recent position is with OXONIQ HEALTHCARE PRIVATE LIMITED as a Individual Promoter. The first company Ram Shankar Shukla was appointed to as a director was SENBIAN PHARMA PRIVATE LIMITED. Ram Shankar Shukla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Ram Shankar Shukla is currently associated with 2 companies in various capacities such as Director and Individual Promoter. They serve as a Director at SENBIAN PHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 08904050.Ram Shankar Shukla is currently involved in 2 different roles. Their most recent position is with OXONIQ HEALTHCARE PRIVATE LIMITED as a Individual Promoter. The first company Ram Shankar Shukla was appointed to as a director was SENBIAN PHARMA PRIVATE LIMITED. Ram Shankar Shukla is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Call +91 81049 46419 and we'll pull the verified contact details for you.
Current Companies (2)
Current LLPs (0)
Past Companies (0)
1y 2m 7 Months Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SENBIAN PHARMA PRIVATE LIMITED | Director | 05-Oct-2020 |
| SENBIAN PHARMA PRIVATE LIMITED | Individual Promoter | 05-Oct-2020 |
| OXONIQ HEALTHCARE PRIVATE LIMITED | Individual Promoter | 14-Dec-2020 |
| OXONIQ HEALTHCARE PRIVATE LIMITED | Director | 14-Dec-2020 |